📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: CoGenesys

1.1 - Company Overview

CoGenesys Logo

CoGenesys

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of peptide- and protein-based medicine development for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to CoGenesys

Biotest Logo

Biotest

HQ: Germany Website
  • Description: Provider of plasma proteins and biotherapeutic drugs for haematology, clinical immunology and intensive care medicine, developing, manufacturing and marketing immunoglobulins and clotting factors, with a value chain extending from pre-clinical and clinical development to worldwide marketing and distribution.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biotest company profile →
Ablynx Logo

Ablynx

HQ: Belgium Website
  • Description: Provider of a proprietary Nanobody® technology platform for the discovery and development of therapeutic nanobodies—small single-domain antibody fragments—targeting serious human diseases including inflammation, haematology, oncology and pulmonary disease, with approximately 25 projects in the pipeline.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ablynx company profile →
Pinteon Therapeutics Logo

Pinteon Therapeutics

HQ: United States Website
  • Description: Provider of a monoclonal antibody therapeutic, PNT001, targeting cis-pT231 tau to reduce neurodegeneration and cognitive impairment in traumatic brain injury, chronic traumatic encephalopathy, Alzheimer's disease, and progressive supranuclear palsy; advancing clinical studies of this novel antibody.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pinteon Therapeutics company profile →
Barentz Logo

Barentz

HQ: The Netherlands Website
  • Description: Provider of specialty ingredients for pharmaceutical, personal and home care, food & nutrition, and animal nutrition markets worldwide, representing world-class suppliers and Barentz-owned producers. Includes APIs, excipients, nutraceuticals, functional actives, intermediates, alternative proteins, clean label, sugar/sodium reduction, fortification, and animal nutrition concepts, plus technical/formulation support and supply chain, warehousing and transport solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Barentz company profile →
Genkyotex Logo

Genkyotex

HQ: Switzerland Website
  • Description: Provider of innovative drugs and platform technology that block NOX enzymes producing oxygen radicals to treat oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy. Offerings include setanaxib and a NOX inhibitor platform.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genkyotex company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for CoGenesys

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to CoGenesys

2.2 - Growth funds investing in similar companies to CoGenesys

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for CoGenesys

4.2 - Public trading comparable groups for CoGenesys

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to CoGenesys

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About CoGenesys

What does CoGenesys do?

CoGenesys is a provider of peptide- and protein-based medicine development for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.

Who are CoGenesys's competitors?

CoGenesys's competitors and similar companies include Biotest, Ablynx, Pinteon Therapeutics, Barentz, and Genkyotex.

Where is CoGenesys headquartered?

CoGenesys is headquartered in United States.

How many employees does CoGenesys have?

CoGenesys has 1,000 employees 🔒.

When was CoGenesys founded?

CoGenesys was founded in 2010 🔒.

What sector and industry vertical is CoGenesys in?

CoGenesys is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for CoGenesys

Who are the top strategic acquirers in CoGenesys's sector and industry

Top strategic M&A buyers and acquirers in CoGenesys's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for CoGenesys?

Top strategic M&A buyers groups and sectors for CoGenesys include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in CoGenesys's sector and industry vertical

Which are the top PE firms investing in CoGenesys's sector and industry vertical?

Top PE firms investing in CoGenesys's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in CoGenesys's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in CoGenesys's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in CoGenesys's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to CoGenesys include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in CoGenesys's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for CoGenesys?

The key public trading comparables and valuation benchmarks for CoGenesys include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for CoGenesys for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for CoGenesys with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in CoGenesys's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for CoGenesys with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in CoGenesys's' sector and industry vertical?

Access recent funding rounds and capital raises in CoGenesys's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for CoGenesys